NEXANS ● The stock, which is currently worth 2019 to 0.45 times its sales, is clearly overvalued in comparison with peers.
● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● The tendency within the weekly time frame is positive above the technical support level at 29.24 EUR
Weaknesses
● Stock prices approach a strong long-term resistance in weekly data at EUR 37.3.
● The stock is close to a major daily resistance at EUR 37.36, which should be gotten rid of so as to gain new appreciation potential.
● The company has insufficient levels of profitability.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● The company's earnings releases usually do not meet expectations.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the past year, analysts have significantly revised downwards their profit estimates.
